Q1 2022 Updates
Hi everyone,
-
I’ve been mostly incredibly hard at work with New Science.
- Announced a one-year fellowship. We’ll provide young life scientists with a bench in Cambridge, Massachusetts with access to world-class shared equipment, an $80k stipend, a $100k in project costs, and a custom package for every project. If you have really smart friends doing biology, let them know!
- Accepted several incredibly smart fellows for the summer.
- Got featured in the Atlantic.
- Continuing to hire and always fundraising.
-
Published Theses on Sleep.
- Natália Mendonça published Counter-theses on Sleep, getting 3x karma on LessWrong (see comments for a bit of back-and-forth between us).
- Got a Muse S headband. I want to run an experiment during which I’ll sleep ~5 hours a day for 28 days and will then spend 7-14 days not restricting my sleep and proving with Science that my brain waves are normal when I don’t restrict sleep to everyone who thinks I’m a mutant or something.
- Hope to publish a big post on O-1 visa in Q2
-
Got several of my friends out of Russia in early March. Contrary to the information I had, the borders have not closed yet. Hopefully the war will end soon, with Russia safely isolated from the rest of the world.
- In latest news, a Russian ballistic rocket (with “For Children” written on it) was deliberately launched at an Ukrainian railway station that was evacuating civilians, killing more than 50, including 5 kids.
- My wife vetoed me burning my Russian passport and my immigration lawyer told me in strongest terms that I should not renounce the Russian citizenship yet 😓
-
Elsewhere:
- https://stratechery.com/2022/the-intel-split/ (Intel is becoming TSMC’s customer)
- https://www.lesswrong.com/posts/5DKqK3hEzzBoGF47C/consider-taking-zinc-every-time-you-travel
- Chris Beiser:
pretty wild how there’s social pressure on high schoolers/college students to set up half-real volunteer/nonprofit groups, and hype them up with no consideration for how long they last or accomplishments where, when adults do this, we call it “being a con man”
- Nick Jikomes:
Just learned that fluvoxamine, a common SSRI used to treat depression and other psychiatric conditions, increases the half-life of caffeine in the bloodstream.
Like, to an absurd degree
- Black Hawk Down - The Battle of Mogadishu 1993, Part 1 - Animated
Best,
Alexey